Brief: Neurotech International Seeks Trading Halt
04/07/2022 24:34
July 4 (Reuters) - Neurotech International NTI.AX :
* TRADING HALT-NTI.AX
* SEEKS TRADING HALT PENDING ANNOUNCEMENT REGARDING RESULTS
OF
ITS PHASE I/II CLINICAL STUDY
Source text for Eikon: ID:nASX4GhyHb
Further company coverage: NTI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurotech International
See all newsBrief: Neurotech International Says Anthony Filippis Resigns As CEO, MD
Brief: Neurotech International Appoints Mark Davies As Executive Chairman
Brief: Neurotech International Receives Binding Commitments For Around A$4.50 Million In Placement At A$0.014 Per Share
Australia's Neurotech International slips to a month low on discounted placement
Brief: Neurotech International Requests Trading Halt